Ribupatide
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
Fujian Shengdi Pharmaceutical Co · Phase 3 · Recruiting · Enrollment 675
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.